NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Resolute Science

Resolute Science

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://resolutescience.com/

Last Round

Seed Round

Apr 3, 2026

Total Funding Raised

$4.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Resolute Science is a biotechnology company that is advancing a pipeline of first-in-class synthetic drug conjugates for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug delivery platformtargeted cancer therapysolid tumorstumor-associated macrophagesTAMsdrug discoveryoncology biotechpreclinical researchsarcoma treatmentdrug conjugatesbiotech startuptherapeutic pipelinecancer drug developmentbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resolute Science Comps

Public and private peers based on sector, stage, and business model.

Resolute Science comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Resolute Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 3, 2026
SeedFeb 5, 2025
GrantSep 24, 2024
AcceleratorSep 11, 2024
GrantJul 11, 2024
Grant
Aug 1, 2023

Resolute Science Investors

Notable investors and investment history

Resolute Science investors
InvestorRounds
National Cancer InstituteGrant
CureboundGrant
TL FoundationAccelerator
NuFundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    $3M Seed Round raised

  • May 5, 2025

    Grew 75% QoQ, from 4 to 7 employees.

Resolute Science Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Resolute Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resolute Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range8
Year Founded2020
Last FundingApr 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.